Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.copbio.2016.02.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Botulinum Toxin and Migraine: Goals and Perspectives.
Toxins (Basel)
December 2024
Headache Center, Neurological Clinic, "L. Amaducci", AOUC Policlinico, Piazza G. Cesare, 11, 70124 Bari, Italy.
This Special Issue aims to provide an updated overview of the current state and future perspectives of botulinum toxin treatment for migraine [...
View Article and Find Full Text PDFEuropean biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.
Front Allergy
December 2024
Department of Otorhinolarynogology and Head/Neck Surgery, Amsterdam University Medical Centres, Location AMC, University of Amsterdam, Amsterdam, Netherlands.
The European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized the first European Biologic Training Course (EBTC) in Brussels on 1st March 2024. The aim of this hybrid EBTC including both face-to-face and web-based participation was to address the educational needs of physicians dealing with asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) on the clinically relevant aspects of diagnosing and treatment with biologics. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic respiratory diseases through the implementation of optimal patient care via educational, research, and advocacy activities.
View Article and Find Full Text PDFBrain tumor-related epilepsy: an overview on neuropsychological, behavioral, and quality of life issues and assessment methodology.
Front Neurol
December 2024
Center for Tumor-Related Epilepsy, UOSD Neuro-oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Brain tumor-related epilepsy (BTRE) is a rare disease in which brain tumor (BT) and epilepsy overlap simultaneously and can have a negative impact on a patient's neuropsychological, behavioral, and quality of life (QoL) spheres. In this review we (a) addressed the main neuropsychological, behavioral, and QoL issues that may occur in BTRE patients, (b) described how BT, BTRE, and their respective treatments can impact these domains, and (c) identified tools and standardized evaluation methodologies specific for BTRE patients. Neuropsychological disorders and behavioral issues can be direct consequences of BTRE and all related treatments, such as surgery, anti-cancer and anti-seizure medication, corticosteroids, etc.
View Article and Find Full Text PDFObservations on the Journal Metrics and Citation Overview of Archives of Bone and Joint Surgery.
Arch Bone Jt Surg
January 2024
Orthopedics Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Navigating the unseen peril: safeguarding medical imaging in the age of AI.
Front Artif Intell
December 2024
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
In response to the increasing significance of artificial intelligence (AI) in healthcare, there has been increased attention - including a Presidential executive order to create an AI Safety Institute - to the potential threats posed by AI. While much attention has been given to the conventional risks AI poses to cybersecurity, and critical infrastructure, here we provide an overview of some unique challenges of AI for the medical community. Above and beyond obvious concerns about vetting algorithms that impact patient care, there are additional subtle yet equally important things to consider: the potential harm AI poses to its own integrity and the broader medical information ecosystem.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!